ArticleOncoimmunology2022

Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1.

Dafne C A Quixabeira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.